Variant report
Variant | esv3372956 |
---|---|
Chromosome Location | chr5:1767977-1770525 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1768482..1770789-chr5:1865352..1867896,2 | MCF-7 | breast: | |
2 | chr5:1769275..1771378-chr5:1773959..1777046,3 | MCF-7 | breast: | |
3 | chr5:1767863..1770481-chr5:1799119..1801019,2 | K562 | blood: | |
4 | chr5:1769289..1773807-chr5:1880777..1884094,4 | MCF-7 | breast: | |
5 | chr5:1767882..1769417-chr5:1769620..1771707,2 | MCF-7 | breast: | |
6 | chr5:1767882..1769417-chr5:1769620..1771707,2 | MCF-7 | breast: | |
7 | chr5:1769767..1771848-chr5:1781925..1784908,2 | K562 | blood: | |
8 | chr5:1769932..1772068-chr5:1795879..1799269,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000171421 | chromatin interactions |
ENSG00000249116 | chromatin interactions |
ENSG00000113430 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568727811 | chr5:1767995-1767996 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs539426881 | chr5:1768067-1768068 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs116590487 | chr5:1768075-1768076 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs567159436 | chr5:1768087-1768088 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs547584857 | chr5:1768099-1768100 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs534400548 | chr5:1768105-1768106 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs370575831 | chr5:1768176-1768177 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs566617716 | chr5:1768178-1768179 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs10061601 | chr5:1768187-1768188 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs537918282 | chr5:1768209-1768210 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs556605106 | chr5:1768244-1768245 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs9312953 | chr5:1768404-1768405 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs544998142 | chr5:1768461-1768462 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs564081905 | chr5:1768475-1768476 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs555693321 | chr5:1768476-1768477 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs572762791 | chr5:1768487-1768488 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs540041201 | chr5:1768526-1768527 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs561704970 | chr5:1768540-1768541 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs567601996 | chr5:1768549-1768550 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs529001711 | chr5:1768608-1768609 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs550440928 | chr5:1768642-1768643 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs73022150 | chr5:1768652-1768653 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs533008489 | chr5:1768701-1768702 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs377089610 | chr5:1768703-1768704 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs112443270 | chr5:1768705-1768706 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs370262726 | chr5:1768707-1768708 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs534463949 | chr5:1768736-1768737 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs188525695 | chr5:1768829-1768830 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs375363092 | chr5:1768846-1768847 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs143843311 | chr5:1768914-1768915 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs148191133 | chr5:1768915-1768916 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs141167152 | chr5:1768983-1768984 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs377516235 | chr5:1768993-1768994 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs577572592 | chr5:1768999-1769000 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs112748892 | chr5:1769003-1769004 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs28575986 | chr5:1769006-1769007 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs5013187 | chr5:1769019-1769020 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs5013188 | chr5:1769025-1769026 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs71595068 | chr5:1769038-1769039 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs71595069 | chr5:1769043-1769044 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs372931634 | chr5:1769051-1769052 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs457262 | chr5:1769058-1769059 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs5013189 | chr5:1769064-1769065 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs464319 | chr5:1769074-1769075 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs5013190 | chr5:1769077-1769078 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs464793 | chr5:1769082-1769083 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs186822454 | chr5:1769090-1769091 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs5013192 | chr5:1769091-1769092 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs183763935 | chr5:1769103-1769104 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs188879636 | chr5:1769110-1769111 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1763800-1772200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr5:1764000-1771400 | Weak transcription | H1 Cell Line | embryonic stem cell |
3 | chr5:1764400-1768400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr5:1765800-1768400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr5:1767600-1768000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
6 | chr5:1767600-1768200 | Enhancers | Ovary | ovary |
7 | chr5:1767600-1769000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr5:1767800-1769000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr5:1768200-1768400 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
10 | chr5:1768400-1768600 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr5:1768400-1768800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr5:1768600-1769200 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr5:1769200-1769400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr5:1769400-1770200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr5:1770000-1770200 | Enhancers | Fetal Heart | heart |
16 | chr5:1770200-1770800 | Weak transcription | Fetal Heart | heart |
17 | chr5:1770200-1771000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr5:1770200-1771600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr5:1770400-1770600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |